Top Industry Leaders in the Genetic Engineering Market
Editas Medicine Received FDA Fast Track designation for their EDIT-101 gene therapy candidate for Leber congenital amaurosis 10 in September 2023.
Intellia Therapeutics Successfully dosed the first participant in their phase 1/2 clinical trial for NTLA-2001, a CRISPR-based therapy for transthyretin amyloidosis in July 2023.
Crispr Therapeutics Announced strategic partnerships with Bayer and Vertex Pharmaceuticals in December 2023 for developing gene therapies for specific diseases.
Synthego Launched their new Gene Editing & Engineering Platform in May 2023, offering comprehensive services for researchers and companies working with CRISPR technologies.
Twist Bioscience Collaborated with Bayer in October 2023 to utilize their DNA synthesis technology for high-throughput antibody discovery.
List of Genetic Engineering Key Companies in the Market
- Thermo Fisher Scientific Inc.
- Cibus
- Recombinetics Inc.
- Sangamo
- Merck KGaA
- Lonza
- Precision Biosciences
- OriGene Technologies Inc.
- Intellia Therapeutics Inc.
- Caribou Biosciences Inc.